Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Jun 1, 2022 - 16:42
 0
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines

Sangri Today Sangri Today is a Weekly Bilingual Newspaper and website of news and current affairs that publishes news reports from various places, from general reports.
Advertisement

Want to get your story featured as above? click here!

Advertisement

Want to get your story featured as above? click here!